Routine screening for BRCA1 gene mutation unnecessary
This article was originally published in Clinica
Widespread screening of women for the BRCA1 breast cancer susceptibility gene is not warranted because the number of cancers linked to the gene is so low, two US studies have suggested. However, women with a strong family history of breast or ovarian cancer should be tested, the researchers said.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.